- Home
- TTNP vs EVOK Comparison
TTNP vs EVOK Comparison
Compare TTNP & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTNP
- EVOK
- Stock Information
- Founded
- TTNP 1991
- EVOK 2007
- Country
- TTNP United States
- EVOK United States
- Employees
- TTNP N/A
- EVOK N/A
- Industry
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- TTNP Health Care
- EVOK Health Care
- Exchange
- TTNP Nasdaq
- EVOK Nasdaq
- Market Cap
- TTNP 5.4M
- EVOK 5.4M
- IPO Year
- TTNP 1996
- EVOK 2013
- Fundamental
- Price
- TTNP $4.93
- EVOK $5.12
- Analyst Decision
- TTNP
- EVOK
- Analyst Count
- TTNP 0
- EVOK 0
- Target Price
- TTNP N/A
- EVOK N/A
- AVG Volume (30 Days)
- TTNP 49.3K
- EVOK 104.5K
- Earning Date
- TTNP 08-26-2025
- EVOK 08-14-2025
- Dividend Yield
- TTNP N/A
- EVOK N/A
- EPS Growth
- TTNP N/A
- EVOK N/A
- EPS
- TTNP N/A
- EVOK N/A
- Revenue
- TTNP N/A
- EVOK $12,794,859.00
- Revenue This Year
- TTNP N/A
- EVOK $57.82
- Revenue Next Year
- TTNP N/A
- EVOK $59.12
- P/E Ratio
- TTNP N/A
- EVOK N/A
- Revenue Growth
- TTNP N/A
- EVOK 70.02
- 52 Week Low
- TTNP $3.03
- EVOK $1.94
- 52 Week High
- TTNP $14.80
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- TTNP 62.92
- EVOK 55.77
- Support Level
- TTNP $4.64
- EVOK $4.61
- Resistance Level
- TTNP $5.17
- EVOK $5.70
- Average True Range (ATR)
- TTNP 0.29
- EVOK 0.52
- MACD
- TTNP 0.11
- EVOK -0.03
- Stochastic Oscillator
- TTNP 83.67
- EVOK 71.01
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.